Logos Global Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Hold |
4,217,627
| – | – | 1.57% | 19 |
|
|
2025
Q1 | $16.3M | Hold |
4,217,627
| – | – | 2.89% | 15 |
|
|
2024
Q4 | $26M | Hold |
4,217,627
| – | – | 3.04% | 12 |
|
|
2024
Q3 | $22.7M | Sell |
4,217,627
-814,874
| -16% | -$4.38M | 2.45% | 16 |
|
|
2024
Q2 | $16.9M | Hold |
5,032,501
| – | – | 1.36% | 16 |
|
|
2024
Q1 | $20.3M | Hold |
5,032,501
| – | – | 1.64% | 18 |
|
|
2023
Q4 | $13.3M | Hold |
5,032,501
| – | – | 1.24% | 18 |
|
|
2023
Q3 | $11.9M | Buy |
5,032,501
+2,235,000
| +80% | +$5.27M | 1.58% | 22 |
|
|
2023
Q2 | $17.6M | Hold |
2,797,501
| – | – | 2.4% | 15 |
|
|
2023
Q1 | $16.1M | Hold |
2,797,501
| – | – | 2.31% | 15 |
|
|
2022
Q4 | $28.7M | Hold |
2,797,501
| – | – | 3.36% | 11 |
|
|
2022
Q3 | $46.8M | Hold |
2,797,501
| – | – | 5.75% | 5 |
|
|
2022
Q2 | $39.2M | Hold |
2,797,501
| – | – | 7.19% | 4 |
|
|
2022
Q1 | $45.2M | Buy |
2,797,501
+25,000
| +0.9% | +$404K | 5.86% | 4 |
|
|
2021
Q4 | $59.4M | Hold |
2,772,501
| – | – | 6.12% | 3 |
|
|
2021
Q3 | $40.7M | Buy |
2,772,501
+40,000
| +1% | +$588K | 2.94% | 12 |
|
|
2021
Q2 | $54.3M | Hold |
2,732,501
| – | – | 4.57% | 3 |
|
|
2021
Q1 | $81.7M | Buy |
+2,732,501
| New | +$81.7M | 7.97% | 3 |
|